Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pharmagreen Biotech Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Sep-30-18Sep-30-17
   10-K10-K10-K10-K/A10-KS-1
Revenues  0.00.80.00.00.00.0
            Revenue growth  -100.0%-2375.0% -100.0%70.4% 
Cost of goods sold  0.00.0-1.00.60.00.0
Gross profit  0.00.80.9-0.60.00.0
            Gross margin   100.0%-2836.2% 0.0%0.0%
Selling, general and administrative   [+]0.10.20.30.20.20.2
Research and development     0.00.0 
Other operating expenses  1.01.31.2-0.10.70.5
EBIT   [+]-1.1-0.7-0.5-0.8-0.9-0.7
            EBIT margin   -98.8%1465.4% -5080.5%-7173.1%
Non-recurring items   [+]  0.0 -0.1 
Interest expense  0.00.70.30.0 0.1
Other income (expense), net   [+]0.3-3.1-1.60.0-0.30.0
Pre-tax income  -0.9-4.5-2.4-0.8-1.1-0.8
Income taxes  0.00.00.00.00.0-0.2
            Tax rate  0.0% 0.0%0.0%0.0%21.3%
Minority interest  0.00.00.00.0  
Earnings from continuing ops  -0.9-4.5-2.5-0.8-1.1-0.9
Earnings from discontinued ops       0.2
Net income  -0.9-4.5-2.5-0.8-1.1-0.8
            Net margin   -602.1%7503.3% -6251.9%-7663.2%
   
Basic EPS   [+]$0.00($0.02)($0.03)($0.01)($0.04)($0.05)
Diluted EPS   [+]$0.00($0.01)($0.01)($0.01)$0.00($0.05)
   
Shares outstanding (basic)   [+]218.7293.782.176.824.820.6
Shares outstanding (diluted)   [+]403.7326.0388.476.8293.120.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy